Euromonitor: Efficacy overtakes novelty as key driver of ingredient value
Consumers are rewarding products delivering proven results over novel ingredients, creating growth opportunities across food, drink and beauty.
GLP-1
ShopRite launches free starter kits for customers beginning GLP-1 medications
The retailer updates program first introduced earlier this year.
GoodRx launches employer direct weight loss offering
New program gives employers flexible access to GLP-1 medications and clinical support without requiring changes to existing health plans.
IFF names ten consumer moments reshaping food and beverage innovation in the GLP-1 era
New research reveals how smaller, more intentional eating occasions are creating new opportunities for nutrition, flavor and renewed enjoyment.
NACDS research highlights pharmacy’s role in GLP-1 care
“A prescription is a beginning, not a finish line,” NACDS president Steve Anderson wrote.
U.S. News survey reveals what actually drives GLP-1 telehealth success
Patients seek out thorough medical screenings to get started, but access to behavioral guidance and lifestyle resources makes the difference between minimal results and major weight loss.
Walmart workers will get GLP-1s for free
The company will offer Novo Nordisk's Ozempic and Lilly's Mounjaro for type 2 diabetes at no cost after a new prior authorization
Patients increasingly bypass insurance to pay cash for GLP-1 prescriptions, pharmacists say
The trend reflects the rapidly evolving GLP-1 marketplace.
Navitus launches new approach to GLP-1 access and affordability
The new offering includes DirectAccess, a direct-to-consumer option that provides eligible members access to GLP-1 medications for weight management outside the traditional pharmacy benefit.
Amazon One Medical expands on-demand GLP-1 care to 48 states and Washington, D.C.
The program includes upfront GLP-1 costs and an option for on-demand care—increasing patient access and choice for weight loss care.
MOBI introduces GLP-1 Home Wellness Kit to track health at home
MOBI is addressing a practical at-home need.
GLP-1 users are spending nearly 4x more on fitness than other consumers, new report reveals
The Consumer Collective's national study of 500 U.S. adults shows GLP-1 users spend $449 a month on fitness, against $120 for non-users.
Study finds Zepbound cuts healthcare costs for older adults with obesity
Study shows sustained Zepbound use in older adults with obesity lowers costs, reinforcing the potential value of the Medicare GLP-1 Bridge program.
U.S. News debuts 2026-2027 best GLP-1 telehealth platform ratings
Inaugural ratings evaluate leading online GLP-1 platforms to help consumers make informed decisions in the fast-growing weight management market.
CVS Health broadens consumer access to GLP-1 weight management
Offers all FDA approved GLP-1s, whether through insurance or cash-pay options.
Publix pharmacies join Medicare GLP-1 Bridge program for eligible beneficiaries
The GLP-1 medications currently available through the program include Foundayo, Wegovy in both injectable and tablet forms, and Zepbound KwikPen.